Free Republic

The vaccine advisory panel to the Centers for Disease Control and Prevention (CDC) said on Thursday that the benefits of Johnson & Johnson’s COVID-19 vaccine still outweigh the risk of a serious, but rare, neurological disorder following vaccination. The Advisory Committee on Immunization Practices met to discuss the incidence of Guillain-Barré syndrome (GBS) following a J&J shot and agreed that the vaccine should continue to be used in people 18 and older under the Food and Drug Administration’s (FDA) emergency use authorization, saying that the vaccine’s benefits far outweigh the risks. GBS is a condition where the individual’s immune system...

The Food and Drug Administration (FDA) announced on July 12 that it is updating the label on the Johnson & Johnson COVID-19 vaccine to include a warning about the risk of developing Guillain-Barré syndrome, (GBS) a rare and sometimes deadly autoimmune disorder in which the body attacks and damages nerves, according to the Centers for Disease Control and Prevention (CDC). Anywhere between 3,000 and 6,000 people develop Guillain-Barré syndrome each year, per the CDC. For some people, a full recovery just takes a few weeks; for others, it can take a few years. “Reports of adverse events following use of...

Johnson & Johnson and AstraZeneca-University of Oxford have begun studying whether their COVID-19 vaccines can be modifiedBoth shots have been linked to a risk of blood clots along with a low platelet-count condition known as thrombocytopeniaScientists hope to identify the causes behind the blood clots and maybe re-engineer the shots by next yearIn the U.S., J&J's vaccine has been linked to 0.3 cases of rare blood clots per 100,000 doses and AstraZeneca's jab linked to 1-2 cases per 100,000It comes one day after it was revealed the FDA is adding a new warning to the label of J&J's vaccine due...

The Johnson & Johnson COVID-19 vaccine is highly effective against the highly transmissible delta variant, the company announced on Thursday (July 1). Though the analysis was conducted on only a small number of participants and hasn't yet been peer-reviewed, it suggests that the Johnson & Johnson vaccine, like the Pfizer and Moderna's vaccines, may provide a buffer for the U.S. against the highly transmissible variant. The findings were submitted as two separate studies to the preprint server bioRxiv. The delta variant (B.1.617.2) was first discovered in India in October 2020, and the World Health Organization designated it a "variant of...

The Food and Drug Administration has instructed Johnson & Johnson to throw out 60 million doses of the COVID-19 vaccine produced at a Baltimore plant out of concern that they may have been contaminated, according to multiple reports. The FDA determined, after review, that the doses were "not suitable for use," NBC News reported. They are allowing two batches of the vaccine, totaling 10 million doses, to be used but with a warning that they cannot guarantee that the plant, which is run by Emergent BioSolutions, had upheld manufacturing standards, according to The New York Times. The Baltimore plant has...

The Johnson & Johnson (J&J) vaccine is a single-dose vaccine that can help prevent COVID-19. It’s the third COVID-19 vaccine authorized by the Food and Drug Administration (FDA) for emergency use in the United States.Large-scale clinical trials in several locations across the globe found that a single dose of the J&J vaccine was effective at preventing COVID-19. They found that the vaccine can also protect against several viral variants.Below, we’ll break down everything we know so far about the efficacy of the J&J COVID-19 vaccine. Continue reading to learn more.How effective is the Johnson & Johnson vaccine?The efficacy of the...

Belgium has halted use of the Johnson and Johnson vaccine for people under the age of 41 after a person who received the jab died. The woman, who was aged under 40, was admitted to a hospital in Belgium and died from severe side effects to the Janssen vaccine on May 21. Officials said she had developed “serious thrombosis and reduced blood platelets” after receiving the one-shot vaccine through her foreign employer outside the Belgian system. Its government is seeking urgent advice from the European Medicines Agency (EMA), the European Union’s drug regulator, before it will consider lifting the suspension....

BOFFINS claim to have cracked the cause of rare blood clots linked to Covid jabs and say they know how to solve it. They say the phenomenon is caused by “floating mutant proteins” which can occur when a vaccine sends the spike protein of the Sars-Cov-2 virus into the wrong part of a cell. Lead scientist Rolf Marschalek said US drugs firm Johnson & Johnson has already been in touch to ask about his team's research at the Goethe University in Frankfurt. But he said he had not yet discussed its findings with AstraZeneca, manufacturer of the Oxford vaccine. He...

A number of 49-year-olds who turned up at Croke Park for Janssen (Johnson & Johnson) Covid-19 vaccine appointments on Saturday were turned away due to being under the age of 50, the Health Service Executive (HSE) has confirmed. A HSE spokeswoman said the National Immunisation Advisory Committe (Niac) guidelines stipulate these vaccines are “not recommended for this age group [under 50] at present”. “When this error was identified we immediately made every effort to contact those affected by phone and text to advise them not to attend their appointment today… We sincerely apologise for any inconvenience caused,” she added. Niac...

Employers may be liable for ‘any adverse reaction’ from mandated coronavirus shots: OSHAIt’s also possible that employers requiring the injections may be held legally liable for violating federal law.WASHINGTON, D.C., May 10, 2021 (LifeSiteNews) — The federal Occupational Safety and Health Administration (OSHA) has put employers on notice that should they attempt to require employees to receive injections of experimental COVID-19 gene-therapy vaccines a resulting adverse reaction will be considered “work-related” for which the employer may be held liable.OSHA released its new guidance on April 20 under a “Frequently Asked Questions” section of its website having to do with COVID-19...

Two months after it first reached the arms of people in the United States, Johnson & Johnson’s COVID-19 vaccine is once again being administered following a 10-day pause over blood-clotting concerns. At the time of publication, over 8.7 million doses of the single-shot vaccine have been delivered so far, per the Centers for Disease Control and Prevention (CDC).At the recommendation of the CDC and the Food and Drug Administration (FDA), the Johnson & Johnson COVID-19 vaccine was temporarily unavailable last month as the agencies investigated sporadic reports of a rare, potentially deadly blood-clotting disorder in six patients—all women between the...

German Health Minister Jens Spahn announced Monday the country was making the single-shot Johnson & Johnson COVID-19 vaccine available to all adults, lifting a prioritization that limited the shot only to those 60 and older. Like the AstraZeneca vaccine before it, Germany had limited the use of the Johnson & Johnson shot after several cases of blood clots were reported among younger recipients of the vaccine. The European Medicines Agency (EMA) has said blood clots should be listed as a rare side effect of both the Johnson & Johnson and AstraZeneca shots but that the benefits continue to outweigh risks....

Mayor Bill de Blasio wants to make a jab in the arm the Big Apple’s next great souvenir — by offering the coronavirus vaccine to tourists, he announced Thursday. But the state would need to approve the idea. “This summer you’re going to see tourism come alive again in New York City,” de Blasio said during a City Hall press briefing. “We want to go the extra mile, make it easy for tourists, if they’re here, get vaccinated while you’re here.” The de Blasio administration is hoping to set up mobile immunization sites at popular destinations around the city like...

Denmark will not use the Johnson & Johnson vaccine, the Danish Health Authority announced on Monday, saying in a statement that the country could make adequate progress using other vaccines and did not need to run the risk of a rare, dangerous blood clotting condition that may be linked to the Johnson & Johnson vaccine. The country has halted administering the AstraZeneca vaccine for similar reasons, after two people died of blood clots after being given that vaccine. Denmark had been planning to use the Johnson & Johnson single-dose vaccine before reports emerged about a possible link to the clotting...

Two vaccines – the Johnson & Johnson vaccine in the U.S. and the AstraZeneca vaccine in Europe – have been linked to an increased chance of a rare type of blood clot. Researchers are investigating what causes these clots and are starting to propose some answers. Dr. Mousumi Som, a professor of medicine at Oklahoma State University, explains what these rare clots are and how they are forming after people get vaccinated.1. What are the blood clots?A small number of people in the U.S. have developed dangerous blood clots after receiving the Johnson & Johnson vaccine. The clots have mostly...

The federal government’s decision to pause Johnson & Johnson vaccines for 11 days as scientists studied dangerous blood clotting episodes may ultimately boost confidence in vaccine safety, Dr. Anthony Fauci, chief medical adviser to President Joe Biden, said Sunday.

A FactCheck.org project addressing common COVID-19 “misconceptions” owes its existence to a philanthropic organization that has around 15 percent of its assets tied up in Johnson & Johnson stock. The top of the project homepage reads as follows: “SciCheck’s COVID-19/Vaccination Project is made possible by a grant from the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the foundation.” Interestingly enough, Rep. Thomas Massie (KY-04) has discovered that 15.9 percent of the foundation’s assets consist of Johnson & Johnson common stock. Out of $11.9 million in assets, nearly $1.9 million has been invested...

The Johnson & Johnson single-dose COVID-19 vaccine that was paused last week by the federal government has been given the green light again, despite 15 blood clots and one death that caused the pause in the first place. The Centers for Disease Control (CDC) and the U.S. Food and Drug Administration (FDA) approved the drug's reentry into the vaccine market for emergency use authorization (EUA). "Following a thorough safety review, including two meetings of the CDC's Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the...

The EU's drugs regulator has said that blood clots should be listed as a "very rare" side effect of the Johnson & Johnson Covid-19 vaccine. The European Medicines Agency said in a statement that it had found a "possible link" between the jab and clots. But it added that the benefits of the Covid-19 vaccine outweighed the risks. Out of more than seven million people who have received the jab in the US, eight people developed rare blood clots, including one person who died. Earlier this month, the EMA made the same recommendation for the Covid-19 vaccine produced by Oxford-AstraZeneca....

The Centers for Disease Control and Prevention and the Food and Drug Administration are leaning toward resuming use of the Johnson & Johnson vaccine with a warning about blood clots, sources told CBS News. A decision is expected Friday, more than a week after the vaccine's distribution was paused following reports of rare but dangerous blood clots in eight people under the age of 50. "I think too many people may be scared off by taking the vaccine. They shouldn't be, but perception is everything when it comes to vaccines," said Dr. Peter Hotez, who works at the Texas Children's...